Ind-Swift (INDSWFTLAB) | Stock Overview & Key Data
Ind-Swift Performance Comparison
Stock Range
Today's Range
Low: ₹100.30
High: ₹105.00
on August 18, 2025
52 Week Range
Low: ₹68.72
High: ₹158.56
on May 9, 2025
on September 3, 2024
All-Time High: ₹296.50 on December 20, 2004
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR7.5B
EPS
59.91
P/E Ratio (TTM)
1.69
Forward P/E
N/A
P/B Ratio
0.58
PEG Ratio
-0.02
Div. Yield
N/A
ROE
45.19%
Beta
0.444
Debt to Equity
3.48
Financial Highlights
Profitability
Gross Margin
28.22%
Operating Margin
-2.01%
Profit Margin
40.55%
Returns and Earnings
Return on Assets (TTM)
36.13%
Return on Equity (TTM)
45.19%
EBITDA
INR2.9B
Net Income (TTM)
INR2.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR96.03
Quarterly Revenue Growth (YoY)
360.50%
Quarterly Earnings Growth (YoY)
837.90%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ind-Swift INDSWFTLAB | 7.53B Small-cap | 1.07% | -4.55% | 30.20% | 10.36% | -7.78% | -25.95% | 62.30% | 164.86% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 2.69% | -2.45% | -3.91% | -3.48% | -13.15% | -5.82% | 82.10% | 208.33% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | 0.02% | -9.53% | -1.34% | 4.94% | 0.98% | 32.34% | 65.91% | 88.85% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | -3.92% | -13.01% | -6.93% | -0.76% | -30.12% | -34.25% | -41.92% | -22.97% |
| Aarti Drugs AARTIDRUGS | 44.42B Small-cap | -3.86% | 1.23% | 5.23% | 18.26% | 6.84% | -2.04% | 8.97% | -37.88% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 0.45% | -5.27% | 0.82% | 19.96% | -4.81% | 22.66% | 59.79% | 34.23% |
Ownership & Short Interest
Insider Ownership
57.43%
Institutional Ownership
5.55%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
73K
Average 90-Day Volume
138K
Ind-Swift Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Ind-Swift would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INDSWFTLAB's 52-week high and low?
- In the last 52 weeks, Ind-Swift reached a high of ₹158.56 (on September 3, 2024) and a low of ₹68.72 (on May 9, 2025).
- What is the market cap and P/E ratio for INDSWFTLAB?
- Curious about Ind-Swift's size and valuation? Its market capitalization stands at 7.53B. When it comes to valuation, the P/E ratio (trailing twelve months) is 1.69, and the forward P/E (looking ahead) is N/A.
- Does INDSWFTLAB pay dividends? If so, what's the yield?
- As for dividends, Ind-Swift isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ind-Swift's main competitors or similar companies to consider before investing?
When looking at Ind-Swift, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -5.82% 82.10% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 32.34% 65.91% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.25% -41.92% Aarti Drugs
AARTIDRUGS44.42B Healthcare Drug Manufacturers - Specialty & Generic -2.04% 8.97% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 22.66% 59.79% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ind-Swift Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Ind-Swift's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 45.19%, the Debt to Equity ratio from the most recent quarter is 3.48, and its Gross Profit Margin stands at 28.22%.
- What is the recent revenue and earnings growth for INDSWFTLAB?
- Looking at Ind-Swift's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 360.50%, and quarterly earnings saw a YoY growth of 837.90%.
- How much of INDSWFTLAB stock is held by insiders and institutions?
- Wondering who owns Ind-Swift stock? Company insiders (like executives and directors) hold about 57.43% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.